Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients
Progress in Neuro-Psychopharmacology and Biological Psychiatry
October 28, 2022
Cited by 17
Related Papers
No related papers found
Powered by citation graph analysis